2026 NPPES data Ambulatory Care Pharmacist NPI 1568828390
Verify on CMS →

ALI AZARPIRA

Ambulatory Care Pharmacist in SAN RAFAEL, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 581 beneficiaries · Ambulatory Care Pharmacist avg: 492
Generic prescribing
31%
generic claims · 69% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: ALI AZARPIRA is a Ambulatory Care Pharmacist ([object Object]) practicing in SAN RAFAEL, California with a Medicare Part D prescribing footprint of 2K claims across 581 beneficiaries — 69% brand-name prescribing .

What stands out: ALI AZARPIRA filed 2,262 Medicare Part D claims in 2023 across SAN RAFAEL, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ALI AZARPIRA at a glance

Quality data not reported

NPI registry status

Active

Issued 01/09/2016

NPI 1568828390

Primary specialty

Ambulatory Care Pharmacist

Niche

3,473 US NPIs in this specialty

Medicare Part D claims

2,262 360% vs specialty avg

2023 prescription claims

Specialty avg: 492

Specialty distribution in California

How Ambulatory Care Pharmacist compares to other specialties among California providers

California providers

Ambulatory Care Pharmacist share within California

1. Ambulatory Care Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ambulatory Care Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Ambulatory Care Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ambulatory Care Pharmacist ABMS/AOA estimate

Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALI AZARPIRA is a Ambulatory Care Pharmacist provider practicing in SAN RAFAEL, California, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1568828390. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ALI AZARPIRA appears in the CMS NPPES registry as a Ambulatory Care Pharmacist provider at 100 SMITH RANCH RD, SAN RAFAEL, CA, 94903, with a listed phone of (415) 492-6360. NPI 1568828390 was issued on 01/09/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AZARPIRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,262 prescription claims written by this provider, covering 581 Medicare beneficiaries and totaling roughly $439K in drug spend, split 69% brand-name and 31% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ambulatory Care Pharmacist is a narrow specialty nationwide, with 3,473 enrolled providers across 52 states and an average of 492 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 SMITH RANCH RD
SAN RAFAEL, CA 94903

Provider Details

NPI 1568828390
Specialty Ambulatory Care Pharmacist
Gender Male
NPI Issued 01/09/2016

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ALI AZARPIRA. To verify ALI AZARPIRA's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ALI AZARPIRA — brand share 69.0%
Specialty average (est.)

69% brand-name claims vs 31% generic, on 2,262 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,262
Total Claims
$439K
Total Drug Cost
581
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,870
Total Day Supply
110,306
Brand vs Generic
69% brand / 31% generic
Brand Drug Cost
$358K
Generic Drug Cost
$79K

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
1.19
Gender Split
60% female / 40% male
Age Distribution
<65: 41, 65-74: 289, 75-84: 233, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
671
Symbicort
Budesonide/Formoterol Fumarate
423
Alvesco
Ciclesonide
402
Wixela Inhub
Fluticasone Propion/Salmeterol
241
Montelukast Sodium
213
Breyna
Budesonide/Formoterol Fumarate
57
Metformin Hcl Er
Metformin Hcl
26
Advair Hfa
Fluticasone Propion/Salmeterol
23
Ozempic
Semaglutide
23
Humulin 70-30
Insulin Nph Hum/Reg Insulin Hm
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ambulatory Care Pharmacist Overview

How ALI AZARPIRA fits within the Ambulatory Care Pharmacist landscape nationally.

3,473
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
492
Avg Claims per Provider

ALI AZARPIRA's 2,262 claims are above the specialty average of 492.

Nearby Ambulatory Care Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as AZARPIRA.

Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALI AZARPIRA's specialty?
ALI AZARPIRA specializes in Ambulatory Care Pharmacist and practices in SAN RAFAEL, California.
How much does ALI AZARPIRA prescribe under Medicare Part D?
In 2023, ALI AZARPIRA wrote 2,262 Medicare Part D claims totaling $439K in drug costs for 581 beneficiaries.
Where is ALI AZARPIRA located?
ALI AZARPIRA is located at 100 SMITH RANCH RD, SAN RAFAEL, CA, 94903. Phone: (415) 492-6360.
What is ALI AZARPIRA's NPI number?
ALI AZARPIRA's National Provider Identifier (NPI) is 1568828390, issued on 01/09/2016.
Does ALI AZARPIRA prescribe more brand-name or generic drugs?
ALI AZARPIRA's prescribing is 69% brand-name and 31% generic drugs by claim count, with $358K in brand drug costs.
How many Ambulatory Care Pharmacist providers are there in the US?
There are 3,473 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 492 Medicare Part D claims per year.
What drugs does ALI AZARPIRA prescribe most often?
Based on 2023 Medicare Part D data, ALI AZARPIRA's most frequently prescribed drugs include Albuterol Sulfate Hfa, Symbicort, Alvesco. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALI AZARPIRA accept Medicare?
ALI AZARPIRA appears in CMS Medicare data with 2,262 Part D claims and 581 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALI AZARPIRA's credentials?
ALI AZARPIRA's NPI is 1568828390. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology